These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2159273)

  • 21. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.
    Schneider MR
    J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aqua[1,1-bis(4-hydroxyphenyl)-1,2-diamino-2-phenylethane]- sulfatoplatinum(II), a new compound for the treatment of the mammary carcinoma.
    Gust R
    Arch Pharm (Weinheim); 1994 Jan; 327(1):49-54. PubMed ID: 8117188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Potential antineoplastics, 6. Synthesis of hexestrol derivatives with alkylating side chains].
    Hamacher H; Mangold C
    Arch Pharm (Weinheim); 1983; 316(3):271-81. PubMed ID: 6305306
    [No Abstract]   [Full Text] [Related]  

  • 24. N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity.
    von Angerer E; Egginger G; Kranzfelder G; Bernhauer H; Schönenberger H
    J Med Chem; 1982 Jul; 25(7):832-7. PubMed ID: 6809943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Phenylindenes: development of a new mammary tumor inhibiting antiestrogen by combination of estrogenic side effect lowering structural elements.
    Schneider MR; Ball H
    J Med Chem; 1986 Jan; 29(1):75-9. PubMed ID: 3941415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mammary-tumor-inhibiting antiestrogens of the 3,3'-dihydroxy-alpha, beta-dialkylstilbene type (author's transl)].
    Schneider M; von Angerer E; Kranzfelder G; Schönenberger H
    Arch Pharm (Weinheim); 1980; 313(11):919-25. PubMed ID: 7447652
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens.
    Hartmann RW
    Cancer Treat Rev; 1984 Mar; 11 Suppl A():155-61. PubMed ID: 6329512
    [No Abstract]   [Full Text] [Related]  

  • 28. Hexestrol-linked cytotoxic agents: synthesis and binding affinity for estrogen receptors.
    Köhle H; Krohn K; Leclercq G
    J Med Chem; 1989 Jul; 32(7):1538-47. PubMed ID: 2544725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.
    Schneider MR; Ball H; Schönenberger H
    J Med Chem; 1985 Dec; 28(12):1880-5. PubMed ID: 4068009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammary tumor inhibiting properties of the (S,S)-configurated [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complex.
    Spruss T; Gust R; Müller R; Engel J; Schönenberger H
    Arch Pharm (Weinheim); 1990 Feb; 323(2):99-102. PubMed ID: 2334275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzo[a]carbazole derivatives. Synthesis, estrogen receptor binding affinities, and mammary tumor inhibiting activity.
    von Angerer E; Prekajac J
    J Med Chem; 1986 Mar; 29(3):380-6. PubMed ID: 3950918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (2R*, 3S*)-1-[18F]fluoro-2,3-bis(4-hydroxyphenyl)pentane [( 18F]fluoronor-hexestrol), a positron-emitting estrogen that shows highly-selective, receptor-mediated uptake by target tissues in vivo.
    Landvatter SW; Kiesewetter DO; Kilbourn MR; Katzenellenbogen JA; Welch MJ
    Life Sci; 1983 Nov; 33(19):1933-8. PubMed ID: 6316052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity.
    Polossek T; Ambros R; von Angerer S; Brandl G; Mannschreck A; von Angerer E
    J Med Chem; 1992 Sep; 35(19):3537-47. PubMed ID: 1404234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-(Cyclohexenonyl)-4-(4-hydroxyphenyl)-hexanes: antiandrogenes derived from the estrogen hexestrol.
    Schiller CD; Schneider MR; von Angerer E
    Arch Pharm (Weinheim); 1990 Jul; 323(7):417-20. PubMed ID: 2173517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
    von Angerer E; Birnböck H; Knebel N
    Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes, III: Evaluation of the mammary tumor inhibiting properties.
    Reile H; Spruss T; Müller R; Gust R; Bernhardt G; Schönenberger H; Engel J
    Arch Pharm (Weinheim); 1990 May; 323(5):301-6. PubMed ID: 2383173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiourea and thiosemicarbazide derivatives structurally related to hexestrol: synthesis and anticancer and other pharmacological properties.
    Omar AM; Farghaly AM; Hazzai AA; Eshba NH; Sharabi FM; Daabees TT
    J Pharm Sci; 1981 Sep; 70(9):1075-9. PubMed ID: 6101219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 1. Synthesis and estrogen receptor binding affinity of 2,2'- and 3,3'-disubstituted hexestrols.
    Hartmann RW; Schwarz W; Schönenberger H
    J Med Chem; 1983 Aug; 26(8):1137-44. PubMed ID: 6308256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.